Non-viral gene therapy
Abstract
Non-viral gene therapies are currently under development that employ drug-delivery methods for targeting genes to selected cells in the body, where they express therapeutic gene products. Various methods have been described for non-viral gene therapy, ranging from the direct intramuscular injection of purified DNA to the systemic administration of formulations comprising DNA and lipids, proteins, peptides, or polymers. Products for non-viral gene therapies are designed both for direct administration to patients by conventional routes and for expression of a therapeutic product over a finite period of time in a manner similar to conventional medicines. Initial preclinical and clinical studies indicate that non-viral gene delivery methods exhibit safety profiles similar to conventional pharmaceutical or biological products. Clinical trials have been proposed, or are currently under way, to assess the applicability of non-viral gene therapy for a variety of disorders, including cystic fibrosis, cancer, and peripheral vascular disease. Non-viral techniques may soon allow gene therapy to be applied in clinical practice alongside conventional medicines for the treatment of common diseases.
References (0)
Cited by (95)
Biomedical applications of carbon nanotubes with improved properties
2018, Fullerenes, Graphenes and Nanotubes: A Pharmaceutical ApproachCarbon nanotubes have attracted the interest of many scientists worldwide for biomedical applications since their official discovery in 1991. Over the years, different carbon nanotubes were produced in different ways in order to obtain improved properties for biomedical applications. The unique and outstanding characteristics of carbon nanotubes have made possible the report of many scientific breakthroughs in biological and medical fields. The major information on biomedical applications of different synthesized carbon nanotubes is discussed in this chapter, being of great value for the improvement and design of further promising applications.
Carbon nanotubes: Applications in cancer therapy and drug delivery research
2018, Emerging Nanotechnologies in Dentistry: Second EditionCarbon nanotubes (CNTs) are novel nanocarrier systems that have a wide range of applications in science, engineering, and, the environment. Owing to the possible functionalization of CNTs (i.e., surface-engineering of the nanotubes) with certain chemical groups their physical or biological properties can be manipulated for various applications. In addition to the ability of CNTs to act as carriers for a wide range of therapeutic molecules, their large surface area and possibility to manipulate their surfaces and physical dimensions have been exploited to use them in thermal conductivity in order to photothermally kill cancer cells. This review will discuss the therapeutic applications of CNTs with a major focus on cancer.
Carbon nanotubes: Applications in cancer therapy and drug delivery research
2017, Emerging Nanotechnologies in DentistryCarbon nanotubes (CNTs) are novel nanocarrier systems that have a wide range of applications in science, engineering, and, the environment. Owing to the possible functionalization of CNTs (i.e., surface-engineering of the nanotubes) with certain chemical groups their physical or biological properties can be manipulated for various applications. In addition to the ability of CNTs to act as carriers for a wide range of therapeutic molecules, their large surface area and possibility to manipulate their surfaces and physical dimensions have been exploited to use them in thermal conductivity in order to photothermally kill cancer cells. This review will discuss the therapeutic applications of CNTs with a major focus on cancer.
Carbon Nanotubes: A Promising Carrier for Drug Delivery and Targeting
2016, Nanoarchitectonics for Smart Delivery and Drug TargetingDesign and development of an efficient drug-delivery system is of immense importance, not only for the prevention, diagnosis, and therapy of diseases but also to improve the pharmacological profile of therapeutic molecules. Nanomedicine is a promising field that proposes the utilization of precisely engineered nanomaterials as a new carrier system for the delivery of drugs. An ideal carrier will have targeting effects, and on reaching the effect-relevant site, it can release the drug. In recent years, carbon nanotubes (CNTs) have attracted the fancy of scientists as novel carriers for drug delivery. They are emerging as an extraordinary tool for drug transportation and translocation and have shown significant promise for commercialization. The inherent property of carbon nanotubes, which is to breach the cell membrane of different types of mammalian cells, can be utilized for cellular transport and as a delivery system for functional biological cargos. The transporting capabilities of CNTs, along with the appropriate surface modification and exclusive physicochemical properties, holds great potential in the field of drug delivery.
Some approaches to large-scale manufacturing of liposomes
2014, Emerging Nanotechnologies for ManufacturingLiposomes are nowadays one of the principal nanotechnologies in medical research. They are made of materials that highly resemble those present in mammalian biological membranes, and hence they are safe, biocompatible and biodegradable bilayer vesicles. Although many liposome products have been already commercialized, the difficulty of manufacturing liposomes on a large scale is an obstacle to development and commercialization of many liposome formulations. This review of the literature discusses formulation of liposomes with a focus on proliposome technologies, considering their current applications and future potential in large-scale manufacturing of liposomes.
Carbon Nanotubes in Cancer Therapy and Drug Delivery
2012, Emerging Nanotechnologies in DentistryThis chapter focuses on the use of carbon nanotubes (CNTs) in cancer therapy and drug delivery. CNTs are potentially promising needle-like carriers of small drug molecules as well as macromolecules such as gene and protein. CNTs can be functionalized so that certain molecules are attached to their surfaces via covalent or noncovalent bonding. The needle-like shape of the CNTs enables them to perforate cellular membranes and transport the carried therapeutic molecules to the cellular components. This process is thought to take place via endocytosis. CNTs have exclusive properties that would make them appropriate in the medical field such as their ability to adsorb pathogenic microorganisms and conduct heat. Huge amount of medical research of CNTs has taken place in the area of anticancer therapy. This might be due to the potential toxicity of CNTs as well as the established safety of the vesicle nanocarriers. This chapter presents detailed discussion on CNTs as carriers for drug, gene, protein, and anticancer molecules. Role of CNTs as carriers of immunoactive compounds, proteins and genetic materials is also discussed. The chapter also elaborates use of CNTs for oral cancer therapy.